BBS-Bioactive Bone Substitutes Oyj (BONEH.HE)

EUR 0.06

(-4.3%)

Operating Income Summary of BBS-Bioactive Bone Substitutes Oyj

  • BBS-Bioactive Bone Substitutes Oyj's latest annual operating income in 2023 was -3.36 Million EUR , down -14.06% from previous year.
  • BBS-Bioactive Bone Substitutes Oyj's latest quarterly operating income in 2024 Q2 was -380.50 EUR , up 52.17% from previous quarter.
  • BBS-Bioactive Bone Substitutes Oyj reported an annual operating income of -2.95 Million EUR in 2022, down -14.8% from previous year.
  • BBS-Bioactive Bone Substitutes Oyj reported an annual operating income of -2.57 Million EUR in 2021, up 2.8% from previous year.
  • BBS-Bioactive Bone Substitutes Oyj reported a quarterly operating income of -380.50 EUR for 2024 Q2, up 52.17% from previous quarter.
  • BBS-Bioactive Bone Substitutes Oyj reported a quarterly operating income of -3.36 Million EUR for 2023 FY, down -14.06% from previous quarter.

Annual Operating Income Chart of BBS-Bioactive Bone Substitutes Oyj (2023 - 2014)

Historical Annual Operating Income of BBS-Bioactive Bone Substitutes Oyj (2023 - 2014)

Year Operating Income Operating Income Growth
2023 -3.36 Million EUR -14.06%
2022 -2.95 Million EUR -14.8%
2021 -2.57 Million EUR 2.8%
2020 -2.64 Million EUR -72.21%
2019 -1.53 Million EUR -421.68%
2018 477.47 Thousand EUR 110.99%
2017 -4.34 Million EUR -624.33%
2016 -600 Thousand EUR -9.09%
2015 -550 Thousand EUR -125.09%
2014 -244.34 Thousand EUR 0.0%

Peer Operating Income Comparison of BBS-Bioactive Bone Substitutes Oyj

Name Operating Income Operating Income Difference
Modulight Oyj -12.13 Million EUR 72.25%
Nexstim Plc -1.19 Million EUR -182.097%
Revenio Group Oyj 26.34 Million EUR 112.78%